CD8A and myeloid sarcoma: Of interest, the frequency of CD8 T cells specific for EBV lytic antigens, including BZLF1, in the peripheral blood of patients with relapsing MS was higher during disease flares, while the CD8 T-cell response to EBV latent antigens increased during remissions (19).